Literature DB >> 9858476

Cytoskeletal changes induced by GRAF, the GTPase regulator associated with focal adhesion kinase, are mediated by Rho.

J M Taylor1, M M Macklem, J T Parsons.   

Abstract

Graf, the GTPase regulator associated with focal adhesion kinase was previously shown to have GAP activity for &Rgr; A and Cdc42 in vitro (Hildebrand et al 1996 Mol. Cell Biol. 16: 3169-3178). In this study we sought to determine whether Graf acted at the level of Cdc42, Rho, or both in vivo and whether Graf was a signal terminator or transducer for these proteins. Microinjection of Graf cDNA into subconfluent Swiss 3T3 cells (in the presence of serum) has marked effects on cell shape and actin localization. Graf expression causes clearing of stress fibers followed by formation of long actin based filopodial-like extensions. Similar phenotypes were observed following injection of the Rho-inhibitor, C3 into these cells. The Graf response was dependent on GAP activity, since injection of Graf cDNA containing point mutations in the GAP domain (R236Q or N351V) which block enzymatic activity, does not confer this phenotype. Injection of Graf into Swiss 3T3 cells in which Rho has been down-regulated by serum starvation has no effect on cell morphology. Using this system, we demonstrate that Graf blocks sphingosine-1-phosphate (SPP) stimulated (Rho-mediated) stress fiber formation. Conversely, Graf expression does not inhibit bradykinin stimulated (Cdc42-mediated) filopodial extensions. These data indicate that Graf is a GAP for Rho in vivo. To further substantiate these results we examined the effect of Graf over-expression on Rho-mediated neurite retraction in nerve growth factor (NGF)-differentiated PC12 cells. In PC12 cells, which express relatively high levels of endogenous Graf, overexpression of Graf (but not Graf containing the R236Q mutation) enhances SPP-induced neurite retraction. These data indicate the possibility that Graf may be an effector for Rho in certain cell types.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9858476     DOI: 10.1242/jcs.112.2.231

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  36 in total

Review 1.  Focal adhesion kinases: interest in immunoendocrinology, developmental biology, and cancer.

Authors:  H J Martens; V Geenen
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

2.  alpha2-chimaerin, a Cdc42/Rac1 regulator, is selectively expressed in the rat embryonic nervous system and is involved in neuritogenesis in N1E-115 neuroblastoma cells.

Authors:  C Hall; G J Michael; N Cann; G Ferrari; M Teo; T Jacobs; C Monfries; L Lim
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

3.  Pyk2 Signaling through Graf1 and RhoA GTPase Is Required for Amyloid-β Oligomer-Triggered Synapse Loss.

Authors:  Suho Lee; Santiago V Salazar; Timothy O Cox; Stephen M Strittmatter
Journal:  J Neurosci       Date:  2019-01-09       Impact factor: 6.167

4.  NYAP: a phosphoprotein family that links PI3K to WAVE1 signalling in neurons.

Authors:  Kazumasa Yokoyama; Tohru Tezuka; Masaharu Kotani; Takanobu Nakazawa; Naosuke Hoshina; Yasushi Shimoda; Shigeru Kakuta; Katsuko Sudo; Kazutada Watanabe; Yoichiro Iwakura; Tadashi Yamamoto
Journal:  EMBO J       Date:  2011-09-23       Impact factor: 11.598

5.  Sphingoid base synthesis requirement for endocytosis in Saccharomyces cerevisiae.

Authors:  B Zanolari; S Friant; K Funato; C Sütterlin; B J Stevenson; H Riezman
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

6.  The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both alleles are disrupted in three cases of myelodysplastic syndrome/acute myeloid leukemia with a deletion 5q.

Authors:  A Borkhardt; S Bojesen; O A Haas; U Fuchs; D Bartelheimer; I F Loncarevic; R M Bohle; J Harbott; R Repp; U Jaeger; S Viehmann; T Henn; P Korth; D Scharr; F Lampert
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

7.  TGFB1 is secreted through an unconventional pathway dependent on the autophagic machinery and cytoskeletal regulators.

Authors:  Julian Nüchel; Sushmita Ghatak; Alexandra V Zuk; Anja Illerhaus; Matthias Mörgelin; Katrin Schönborn; Katrin Blumbach; Sara A Wickström; Thomas Krieg; Gerhard Sengle; Markus Plomann; Beate Eckes
Journal:  Autophagy       Date:  2018-03-11       Impact factor: 16.016

8.  Decreased expression of GRAF1/OPHN-1-L in the X-linked alpha thalassemia mental retardation syndrome.

Authors:  Vincenza Barresi; Angela Ragusa; Marco Fichera; Nicolò Musso; Lucia Castiglia; Giancarlo Rappazzo; Salvatore Travali; Teresa Mattina; Corrado Romano; Guido Cocchi; Daniele F Condorelli
Journal:  BMC Med Genomics       Date:  2010-07-06       Impact factor: 3.063

9.  Dual FGF-2 and intergrin alpha5beta1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancy.

Authors:  Judith Barrios; Robert Wieder
Journal:  Cancer Microenviron       Date:  2009-03-18

10.  The GTPase-activating protein GRAF1 regulates the CLIC/GEEC endocytic pathway.

Authors:  Richard Lundmark; Gary J Doherty; Mark T Howes; Katia Cortese; Yvonne Vallis; Robert G Parton; Harvey T McMahon
Journal:  Curr Biol       Date:  2008-11-25       Impact factor: 10.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.